WEKO3
インデックスリンク
アイテム
Molecular mechanisms and clinical features of heart failure
https://fmu.repo.nii.ac.jp/records/2001964
https://fmu.repo.nii.ac.jp/records/200196456c39c68-ccb1-411e-9485-74968e38065f
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
FksmJMedSci_64_p116.pdf (870.9 KB)
|
|
| Item type | デフォルトアイテムタイプ（フル）fmu(1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2018-12-18 | |||||||||
| タイトル | ||||||||||
| タイトル | Molecular mechanisms and clinical features of heart failure | |||||||||
| 言語 | en | |||||||||
| 作成者 |
Suzuki, Satoshi
× Suzuki, Satoshi
× Takeishi, Yasuchika
|
|||||||||
| 権利情報 | ||||||||||
| 権利情報 | © 2018 The Fukushima Society of Medical Science | |||||||||
| 内容記述 | ||||||||||
| 内容記述タイプ | Abstract | |||||||||
| 内容記述 | Heart failure (HF) is a common disease with high prevalence, mortality in hospitalization and after discharge, readmission rates, and burden on healthcare system. Activation of the inflammatory systems is an important role for HF progression, and pentraxin 3 (PTX3) is one of the inflammatory markers. The plasma PTX3 levels increased with advancing the HF severity, and high levels of plasma PTX3 indicated poor prognosis in HF patients. Moreover, we demonstrated that PTX3 had the crucial role for cardiac remodeling under pressure overload using two different genotypes of mice: PTX3 systemic knockout mice and transgenic mice with cardiac-specific overexpression of PTX3.Diuretics are the essential drug for HF treatment, and we designed multicenter, randomized study for evaluating the efficacy and safety of tolvaptan compared to carperitide. Daily urine volume and serum sodium levels were significantly higher, and cardiovascular events were significantly lower in the tolvaptan group than in the carperitide group. Moreover, we investigated the influence of great earthquake in HF patients, and found out that moving into temporary housing by earthquake might affect the incidence of re-hospitalization due to worsening HF.In this review article, we would introduce our research on HF which has various aspects as described above. | |||||||||
| 出版者 | ||||||||||
| 出版者 | The Fukushima Society of Medical Science | |||||||||
| 言語 | ||||||||||
| 言語 | eng | |||||||||
| 書誌情報 |
en : Fukushima Journal of Medical Science 巻 64, 号 3, p. 116-124, 発行日 2018 |
|||||||||
| 関連情報 | ||||||||||
| 関連タイプ | isIdenticalTo | |||||||||
| 識別子タイプ | DOI | |||||||||
| 関連識別子 | https://doi.org/10.5387/fms.2018-17 | |||||||||
| 関連情報 | ||||||||||
| 識別子タイプ | PMID | |||||||||
| 関連識別子 | 30344205 | |||||||||
| 関連情報 | ||||||||||
| 識別子タイプ | ICHUSHI | |||||||||
| 関連識別子 | 2020107746 | |||||||||
| 資源タイプ | ||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||
| 資源タイプ | journal article | |||||||||
| 出版タイプ | ||||||||||
| 出版タイプ | VoR | |||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||
| 収録物識別子 | ||||||||||
| 収録物識別子タイプ | PISSN | |||||||||
| 収録物識別子 | 0016-2590 | |||||||||
| 収録物識別子 | ||||||||||
| 収録物識別子タイプ | EISSN | |||||||||
| 収録物識別子 | 2185-4610 | |||||||||
| 収録物識別子 | ||||||||||
| 収録物識別子タイプ | NCID | |||||||||
| 収録物識別子 | AA0065246X | |||||||||
| 主題 | ||||||||||
| 主題Scheme | Other | |||||||||
| 主題 | heart failure | |||||||||
| 主題 | ||||||||||
| 主題Scheme | Other | |||||||||
| 主題 | inflammation | |||||||||
| 主題 | ||||||||||
| 主題Scheme | Other | |||||||||
| 主題 | diuretics | |||||||||
| 主題 | ||||||||||
| 主題Scheme | Other | |||||||||
| 主題 | earthquake | |||||||||
| 主題 | ||||||||||
| 主題Scheme | Other | |||||||||
| 主題 | prognosis | |||||||||
